Savara Inc.
SVRA
$5.81
-$0.03-0.51%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/3/2025
-
Ticker Report
12/3/2025
-
Simply Wall St
12/2/2025
-
GuruFocus
12/2/2025
-
GuruFocus
12/2/2025
-
Seeking Alpha - Healthcare
12/2/2025
-
SeekingAlpha.com: All News
12/2/2025
-
TipRanks Financial Blog
12/2/2025
-
The Fly
12/2/2025
-
MarketBeat
12/2/2025
-
GuruFocus
12/2/2025
-
GuruFocus
12/2/2025
-
TipRanks Financial Blog
12/2/2025
-
The Fly
12/2/2025
-
Business Wire
12/1/2025
-
Insider Monkey
12/1/2025
-
Zolmax
12/1/2025
-
MarketBeat
11/29/2025
-
MarketBeat
11/29/2025
-
Tickeron - Stocks
11/27/2025
-
MarketBeat
11/26/2025
-
Ticker Report
11/22/2025
-
Ticker Report
11/22/2025
-
Tickeron - Stocks
11/22/2025
-
Tickeron - Stocks
11/22/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, November 12, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
512 614 1848
Address
1717 Langhorne Newtown Road
Langhorne, PA 19047
Langhorne, PA 19047
Country
Year Founded
Business Description
Sector
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company’s lead product candidate is molgramostim, an inhaled granulocyte-macrophage...
more